Influenza, Human: all 2,265 studies

Page 15 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and OlderCompletedNCT02710409Phase 3
• Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and OlderCompletedNCT02708173Phase 1
• Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in AdultsCompletedNCT02691130Phase 2
• Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing HemodialysisCompletedNCT02686398Phase 4
• Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and OlderStatus unknownNCT02665871Phase 1
• Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract InfectionsCompletedNCT02665351Phase 2/3
• Lingdancao Granules in the Treatment of Seasonal InfluenzaStatus unknownNCT02662426Phase 3
• A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet FormulationCompletedNCT02659735Phase 1
• A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III StudyStatus unknownNCT02658409Phase 3
• Tropical Influenza Control Strategies for the ElderlyCompletedNCT02655874Phase 4
• Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.CompletedNCT02644018Phase 3
• Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China MilitaryCompletedNCT02640989Phase 4
• Influenza Vaccine in HIV StudyCompletedNCT02632578
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy AdultsCompletedNCT02624219Phase 1
• Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant RecipientsCompletedNCT02623075
• Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and AdolescentsCompletedNCT02621177Phase 3
• Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and AdolescentsCompletedNCT02621164Phase 3
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT02612922Phase 3
• Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in AdultsCompletedNCT02600585
• Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza InfectionCompletedNCT02597647Phase 1
• Influenza A H3N2 Human Challenge Study in Healthy Adult VolunteersCompletedNCT02594189Phase 1
• Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCTStatus unknownNCT02589574Not applicable
• A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge StudyCompletedNCT02588521Phase 1
• H7N9 Boost in Healthy AdultsCompletedNCT02586792Phase 2
• Project IMPACT Immunizations (IMProving America's Communities Together)CompletedNCT02584036
• Influenza Vaccine and Pneumococcal VaccineCompletedNCT02582047Phase 4
• A Clinical Study of Treating Influenza With Liugan Shuangjie HejiStatus unknownNCT02572583Phase 1/2
• Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)CompletedNCT02567721
• A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With InfluenzaTerminatedNCT02561169Phase 4
• Adjuvanted Influenza Vaccine in Stem Cell TransplantCompletedNCT02560909Phase 4
• Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-driedStatus unknownNCT02560272Phase 3
• T-cell Diversity Following Intranasal and Intramuscular VaccinesCompletedNCT02557802Not applicable
• Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy RegistryCompletedNCT02554409
• A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and OlderCompletedNCT02553343Phase 2
• Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy AdultsCompletedNCT02547792Phase 1
• A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy ChildrenCompletedNCT02541253Phase 3
• ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and AdultsCompletedNCT02529904Phase 2
• Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune ResponsesCompletedNCT02523287Phase 4
• Development of an Intranasal Proteosome Influenza VaccineCompletedNCT02522754Phase 1/2
• The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)Status unknownNCT02500680Phase 1
• Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/BCompletedNCT02487173Not applicable
• Evaluation of Free Air Portable Air Powered RespiratorCompletedNCT02487147Not applicable
• Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza VaccineCompletedNCT02480101Phase 1
• Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital SettingCompletedNCT02478905
• Influenza Challenge Study of VIS410 in Healthy VolunteersCompletedNCT02468115Phase 2
• Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South AfricaStatus unknownNCT02465190
• Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry GrowersCompletedNCT02459171
• Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 YearsStatus unknownNCT02434276Phase 2
• Text Message Reminders for Influenza Vaccine in PregnancyCompletedNCT02428738
• Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling AdultsCompletedNCT02401893
• Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young SubjectsCompletedNCT02398097Phase 4
• Severe Influenza CohortCompletedNCT02392858Not applicable
• A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in MexicoCompletedNCT02378090
• Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese AdultsCompletedNCT02377401Phase 1
• A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or OlderCompletedNCT02366962Phase 3
• Influenza Vaccination Among the Elderly IndividualsCompletedNCT02362919
• Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early AdolescentsCompletedNCT02358083Not applicable
• A Multicenter, Double-blind, Parallel Phase III StudyCompletedNCT02352584Phase 3
• A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and AdolescentsCompletedNCT02352389
• Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in AdultsCompletedNCT02350751Phase 1
• Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly SubjectsCompletedNCT02344134Phase 3
• Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsCompletedNCT02342249Phase 2
• A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in AdultsCompletedNCT02335164Phase 1
• The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza InfectionCompletedNCT02334514
• Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean VolunteerCompletedNCT02330003Phase 1
• Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/ElderlyCompletedNCT02313740
• Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young AdultsCompletedNCT02307851Phase 2
• Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage IIICompletedNCT02302924
• Immune Response to High-Dose vs. Standard Dose Influenza VaccineCompletedNCT02297542Phase 4
• Study of the Immune Response After Vaccination in Multiple Myeloma PatientsCompletedNCT02294487
• Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIVCompletedNCT02293317Phase 2
• Adult Influenza Vaccination Text Message Reminders With Electronic Health Record AlertsCompletedNCT02284594Not applicable
• Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years OldCompletedNCT02274545Phase 1
• The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza VaccineCompletedNCT02269852Phase 4
• A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in ChinaCompletedNCT02269007Phase 1
• Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy PatientsCompletedNCT02267733Phase 1
• Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?CompletedNCT02263027Phase 4
• A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus VaccineCompletedNCT02251288Phase 1
• Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)CompletedNCT02249221Phase 1/2
• Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 YearsStatus unknownNCT02247362Phase 1/2
• Mail Outreach To Increase Vaccination Acceptance Through EngagementCompletedNCT02243774Not applicable
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly PopulationCompletedNCT02236052Phase 2
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in AdultsCompletedNCT02233816Phase 2
• Banlangen Granules Anti-seasonal Influenza StudyStatus unknownNCT02232945Phase 4
• Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 VaccineCompletedNCT02229357Phase 2
• Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New YorkCompletedNCT02227186Not applicable
• MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT02225327Phase 4
• Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 YearsCompletedNCT02215863Phase 4
• Influenza Vaccination in Cancer PatientsTerminatedNCT02213432Not applicable
• H7N9 Mix and Match With MF59 in Healthy Elderly PersonsCompletedNCT02213354Phase 2
• The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza VaccineCompletedNCT02212990Not applicable
• H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...CompletedNCT02206464Phase 1
• Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays UnitsCompletedNCT02198638Not applicable
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of AgeWithdrawnNCT02177734Phase 1
• Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea AdultsCompletedNCT02154308Phase 3
• Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying IntervalsCompletedNCT02151344Phase 1
• Impact of Influenza Vaccination in Pregnancy Video EducationCompletedNCT02151201Not applicable
• Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy AdultsCompletedNCT02148328Phase 1
• A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).CompletedNCT02143882Phase 4
• Clinical Tolerance to a Live Attenuated Vaccine Against Influenza (Flumist®) in a Population Allergic to EggsCompletedNCT02142491

← Influenza, Human overview